FDA Drug Application (021318) for FORTEO by LILLY

Back to FDA Applications sponsored by LILLY

Application Number021318
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage0.75MG/3ML (0.25MG/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameFORTEO
Active IngredientTERIPARATIDE RECOMBINANT HUMAN



Back to FDA Applications sponsored by LILLY